We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DEFENDS MUZZLING EXPERT IN ANTIDEPRESSANT STUDY
FDA DEFENDS MUZZLING EXPERT IN ANTIDEPRESSANT STUDY
April 23, 2004
The FDA last week defended its decision to not allow an agency expert to testify about his conclusions concerning a possible link between the use of some antidepressant drugs and an increased risk of suicide in young people taking the medications.